Hill D B, Kugelmas M
Division of Digestive Diseases and Nutrition, University of Kentucky College of Medicine, Lexington 40536-0084, USA.
Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5. doi: 10.3810/pgm.1998.04.462.
Even modest alcohol ingestion can increase the risk of steatosis, and long-term, excessive consumption can lead to alcoholic hepatitis and eventually cirrhosis. Most patients with clinically significant alcoholic liver disease have histologic findings typical of all three conditions. The only clearly beneficial treatment is abstinence from alcohol. Abstinence in combination with proper nutrition and general supportive care is state of the art. Steatosis is reversible upon withdrawal of alcohol, but alcoholic hepatitis can persist even with abstinence and may progress to cirrhosis. Corticosteroid therapy may reduce short-term mortality rates in patients with moderate or severe alcoholic hepatitis who have hepatic encephalopathy but no evidence of infection or gastrointestinal bleeding. Treatment with colchicine may decrease the risk of cirrhosis; however, once cirrhosis has developed, the liver damage is irreversible. The prognosis is improved with abstinence, but complications (e.g., ascites, gastrointestinal bleeding) often occur. Liver transplantation may be considered in patients with severe complications.
即使适度饮酒也会增加脂肪变性的风险,长期过量饮酒会导致酒精性肝炎,并最终发展为肝硬化。大多数有临床意义的酒精性肝病患者都有这三种病症典型的组织学表现。唯一明确有益的治疗方法是戒酒。戒酒并结合适当的营养和一般支持性护理是目前的最佳治疗方案。脂肪变性在戒酒时是可逆的,但酒精性肝炎即使在戒酒后仍可能持续存在,并可能进展为肝硬化。皮质类固醇疗法可能会降低患有中度或重度酒精性肝炎且有肝性脑病但无感染或胃肠道出血证据的患者的短期死亡率。秋水仙碱治疗可能会降低肝硬化的风险;然而,一旦肝硬化形成,肝脏损伤就是不可逆的。戒酒可改善预后,但并发症(如腹水、胃肠道出血)经常发生。对于有严重并发症的患者可考虑肝移植。